EUVIMEDEUVIMED entdecken
Open Access

Does polygenic risk for substance‐related traits predict ages of onset and progression of symptoms?

Henry R Kranzler iD, Richard Feinn, Heng Xu, Brendan L Ho iD, Divya Saini, Olivia R Nicastro, Anya Jacoby, Sylvanus Toikumo, Joel Gelernter, Emily E Hartwell iD, Rachel L Kember iD

Addiction · 2023

DOI: 10.1111/add.16210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction, 2023. Verfasst von Henry R Kranzler und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Alcoholism, Substance-Related Disorders. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NIDA NIH HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Genetic risk can influence disease progression. We measured the impact of genetic risk for substance use disorders (SUDs) on substance use onset and progression of symptoms. Design, Setting, Participants Using findings from genome‐wide association studies (GWASs) of alcohol use disorder (AUD), opioid use disorder (OUD) and smoking trajectory (SMK) as discovery samples, we calculated polygenic risk scores (PRSs) in a deeply phenotyped independent target sample. Participants in the target sample were recruited from 2000 to 2020 from US inpatient or outpatient settings or through advertisements and comprised 5692 European‐ancestry individuals (EUR) (56.2% male) and 4918 African‐ancestry individuals (AFR) (54.9% male).

Measurements

This study measured age of first substance use, regular use, reported problems and dependence diagnosis and progression from regular use to onset of problems and dependence for alcohol, opioids and smoking. We examined the contribution of PRS to each milestone and progression measure.

Findings

EUR and males reported an earlier onset and shorter progression times than AFR and females, respectively. Among EUR, higher AUD PRS predicted earlier onset and more rapid progression to alcohol‐related milestones ( P < 0.001). Although the AUD PRS was a stronger moderator of problem onset among females ( P = 0.017), it was more predictive of the progression to problems among males ( P = 0.005). OUD and SMK PRS in EUR also predicted earlier onset of the respective milestones ( P < 0.001). Among AFR, where power is lower due to the smaller discovery sample, AUD PRS predicted age of regular alcohol use ( P = 0.039) and dependence ( P = 0.001) and progression from regular use to diagnosis ( P = 0.045), while SMK PRS predicted earlier age of initiation ( P = 0.036).

Conclusions

Genetic risk for SUDs appears to predict substance use milestones and symptom progression among European‐ancestry individuals and, to a lesser extent, African‐ancestry individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismSubstance-Related DisordersFemaleHumansMaleGenome-Wide Association StudyAlcohol DrinkingRisk FactorsEthanolMultifactorial InheritanceGenetic Predisposition to Disease

Stichwörter der Autor:innen

Age of onsetalcohol use disordermilestonesopioid use disorderpolygenic risk scorespredictionprogression measuressmoking

Substanzen

Ethanol

Autor:innen und Institutionen

  • Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Mental Illness Research, Education and Clinical Center, Veterans Integrated Service Network 4, Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
  • Department of Medical Sciences, Frank H. Netter School of Medicine at Quinnipiac University, North Haven, CT, USA.
  • Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • VA Connecticut Healthcare System, West Haven, CT, USA.

ORCID-Profile: Henry R Kranzler, Brendan L Ho, Emily E Hartwell, Rachel L Kember

Förderung

  • CSRD VA
  • NIDA NIH HHS
  • NIAAA NIH HHS
  • NCATS NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Kranzler, H. R., Feinn, R., Xu, H., Ho, B. L., Saini, D., Nicastro, O. R., Jacoby, A., Toikumo, S., Gelernter, J., Hartwell, E. E., & Kember, R. L. (2023). Does polygenic risk for substance‐related traits predict ages of onset and progression of symptoms?. Addiction. https://doi.org/10.1111/add.16210

Vancouver

Kranzler HR, Feinn R, Xu H, Ho BL, Saini D, Nicastro OR, et al. Does polygenic risk for substance‐related traits predict ages of onset and progression of symptoms?. Addiction. 2023. doi:10.1111/add.16210

BibTeX
@article{Kranzler2023,
  author = {Kranzler, Henry R and Feinn, Richard and Xu, Heng and Ho, Brendan L and Saini, Divya and Nicastro, Olivia R and Jacoby, Anya and Toikumo, Sylvanus and Gelernter, Joel and Hartwell, Emily E and Kember, Rachel L},
  title = {Does polygenic risk for substance‐related traits predict ages of onset and progression of symptoms?},
  journal = {Addiction},
  year = {2023},
  doi = {10.1111/add.16210}
}
Kostenlos starten →